Biotechnology Group 'Born Again'
This article was originally published in PharmAsia News
Executive Summary
It is once again on the agenda for the China Biotechnology Group to go public and be listed as a wholly owned entity, after being absorbed by the China Pharmaceutical Corporation (Sinopharm)